Key Points Interested in Moderna, Inc.? Here are five stocks we like better. Moderna shares rose nearly 20% after Science Day ...

The mRNA vaccines approved to treat COVID-19 are safe and effective and show promise in treating other diseases including ...

The three stocks among this year's 20 best S&P 500 performers that aren't in the information-technology sector are Moderna (MRNA), which is in the healthcare sector XX:SP500.35, and Generac (GNRC) and ...

U.S. pharmaceutical company Moderna announced on the 26th (local time) that it will begin developing an “in vivo CAR-T” ...

Other news has also lifted sentiment. The company's recent investor day also included a surprise announcement that it is ...

US President Donald Trump criticized a Supreme Court decision on Monday (June 29) that allows mail-in ballots received after ...

Moderna stock soars on positive updates during the Science Day presentation. Jefferies sees significant further upside in ...

Cancer was a key focus, with programs targeting solid tumors, Lynch syndrome, melanoma, and non-small cell lung cancer.

Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. Among all the awards and mementos Moderna ...

The S&P 500 ended marginally lower on Friday, with a steep drop in AI-related chip stocks and sharp gains in Moderna and ...

The S&P 500 ended marginally lower today, with a steep drop in AI-related chip stocks and sharp gains in Moderna and other ...